중동 및 아프리카 진료소 진단 시장 – 2031년까지의 산업 동향 및 예측

중동 및 아프리카 진료소 진단 시장 분석 및 규모

중동 및 아프리카 진료소 진단 시장은 전통적인 실험실 시설에 대한 접근이 제한적인 원격 또는 서비스가 부족한 지역을 포함하여 다양한 의료 환경에서 광범위하게 적용됩니다. 진료소 진단은 신속한 질병 탐지 및 관리에 중요한 역할을 하며 시기적절하고 효과적인 의료 개입을 촉진합니다. 이러한 기술은 응급실, 1차 진료소 및 가정 의료 환경에서 널리 사용되어 진단 프로세스의 속도와 정확성을 향상시킵니다.

Data Bridge Market Research는 2023년에 15억 4천만 달러였던 중동 및 아프리카의 진료소 진단 시장을 분석했으며, 2031년까지 24억 7천만 달러에 도달할 것으로 예상되며, 2024-2031년 예측 기간 동안 연평균 성장률은 6.1%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

중동 및 아프리카 진료 시점 진단 시장 범위 및 세분화  

시장 정의

진료 시점 진단은 환자 치료가 제공되는 장소 또는 그 근처에서 실시하는 의료 검사 또는 검사를 말합니다. 이러한 검사는 빠른 결과를 제공하도록 설계되어 중앙 실험실로 샘플을 보낼 필요 없이 즉각적인 임상적 결정을 내릴 수 있습니다. 진료 시점 진단은 종종 휴대성이 뛰어나고 사용하기 편리하며 환자의 건강 상태에 대한 빠른 통찰력을 제공합니다.

중동 및 아프리카 진료소 진단 시장 역학

운전자

• 감염병 유행 증가

중동 및 아프리카에서 감염성 질환의 유병률이 증가함에 따라 이 지역의 진료 시점 진단 시장이 크게 성장하고 있습니다. 감염성 질환 의 증가는 진료 시점에 배치할 수 있는 빠르고 효율적인 진단 솔루션에 대한 절실한 필요성을 강조합니다. 진료 시점 진단은 빠르고 정확한 결과를 제공하여 감염성 질환 부담이 증가하는 지역에서 매우 중요한 시기적절한 질병 탐지 및 관리를 용이하게 합니다. 결과적으로 진료 시점 진단 도구에 대한 수요가 급증하여 중동 및 아프리카 시장이 성장할 것으로 예상됩니다.

• 의료 인프라 개발에 대한 강조 증가

Governments and healthcare authorities in the Middle East and Africa are investing significantly in improving healthcare infrastructure. Point-of-care diagnostics are essential in resource-limited settings, allowing for quicker and decentralized testing, aligning with the region's focus on enhancing healthcare accessibility and efficiency. This infrastructure development is a key driver propelling the adoption of point-of-care diagnostics in the region.

Opportunities

• Rising Focus on Non-Communicable Diseases (NCDs) Creates Demand

In the Middle East and Africa, the rising focus on non-communicable diseases (NCDs) presents a significant opportunity for the point-of-care diagnostics market. As the region grapples with an increasing prevalence of conditions such as cardiovascular diseases, diabetes, and cancer, there is a growing demand for rapid and accessible diagnostic solutions. Point-of-care diagnostics offer the advantage of quick and convenient testing, aligning with the healthcare priorities in the region and providing a substantial market opportunity for companies catering to the detection and management of NCDs in these areas.

• Rising Adoption of Telehealth in Remote or Rural Areas

The MEA region is witnessing a surge in the adoption of telehealth and remote patient monitoring solutions, particularly in remote or rural areas. Point-of-care diagnostics align well with these trends, offering the capability for patients to conduct certain tests at home while healthcare providers remotely monitor and manage their conditions. This presents an opportunity for the point-of-care diagnostics market to integrate with evolving healthcare delivery models in the region.

Restraints/Challenges

• Regulatory Challenges Hinders Seamless Operations

The Middle East and Africa point-of-care diagnostics market faces regulatory hurdles due to diverse regulatory frameworks across countries in the region. Companies encounter challenges in navigating and complying with varying sets of regulations, impeding the seamless operation and distribution of point-of-care diagnostics. This regulatory complexity adds a layer of restraint, impacting the efficiency and adaptability of companies in the market.

• Economic Constraints Limits Affordability

Economic factors, such as lower disposable income and financial constraints in certain areas of the Middle East and Africa, can impede the affordability of advanced point-of-care diagnostic devices and tests. This may limit the market growth as the adoption of these technologies relies on the purchasing power of both healthcare institutions and individuals.

This Middle East and Africa point-of-care diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa point-of-care diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2022, LumiraDx Healthcare launched a highly sensitive C - reactive protein (CRP) point-of-care (POC) antigen test in India. This test aids in multiple clinical settings, reducing unnecessary antibiotic prescribing and addressing antimicrobial resistance (AMR)
• October 2022 saw the introduction of Genes2Me Pvt. Ltd's Rapi-Q- Point of Care RT PCR solution for human papillomavirus (HPV) and tuberculosis. This CE-IVD-marked POC solution offers fast results in less than 45 minutes, demonstrating superior performance, high sensitivity, and stable detection
• In September 2020, Instrumentation Laboratory gained FDA clearance for its HemosIL Liquid Anti-Xa test kit, marking a significant step in automated homeostasis testing. It is the first direct, oral anti-coagulant test, contributing to market growth
• In August 2020, Siemens Healthcare Private Limited announced the acquisition of Varian, enhancing their capabilities in the fight against cancer and strengthening their position in the healthcare sector. This strategic move aims to boost the company's credibility in the market.

Middle East and Africa Point-Of-Care Diagnostics Market Scope

The Middle East and Africa point-of-care diagnostics market is segmented on the basis of product, prescription mode, type, platform, end user and distribution channel. The growth amongst these segments will help you analyze growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product

• Glucose Monitoring Products
• Infectious Disease Testing Products
• HIV Testing
• Influenza Testing
• Sexually Transmitted Disease (STD) Testing
• Hepatitis C Testing
• Healthcare-Associated Infection (HAI) Testing
• Tropical Disease Testing
• Respiratory Infection Testing
• Other Infectious Disease Testing
• Cardiometabolic Testing Products
• Pregnancy and Fertility Testing Products
• Coagulation Testing Products
• Tumor/Cancer Marker Testing Products
• Cholesterol Testing Products
• Urinalysis Testing Products
• Hematology Testing Products
• Other POC Products

Prescription Mode

• Prescription-Based Testing
• OTC Testing

Type

• Devices
• Consumables and Kits
• Software and Services
• Accessories

Platform

• Lateral Flow Assays /Immunochromatography Tests
• Molecular Diagnostics
• Immunoassays
• Dipsticks
• Microfluidics

End User

• Professional Diagnostic Centers
• Hospitals
• Clinical Laboratories
• Outpatient Healthcare
• Ambulatory Care Settings
• Home Care
• Research Laboratories
• Others  

Distribution Channel

• Direct Tender
• Retail Pharmacies

Middle East and Africa Point-Of-Care Diagnostics Market Regional Analysis/Insights

The Middle East and Africa point-of-care diagnostics market is segmented on the basis of product, prescription mode, type, platform, end user and distribution channel.

The countries covered in the Middle East and Africa point-of-care diagnostics market report are U Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

South Africa's dominance the point-of-care diagnostics market is attributed to its significant market share held by manufacturers within the country. The presence of key industry players in South Africa, coupled with an escalating diagnostic rate, further solidifies its leadership in the market. The combination of local manufacturing strength and a growing demand for diagnostics underscores South Africa's pivotal role in shaping the landscape of point-of-care diagnostics.

Saudi Arabia dominates the market due to the increasing popularity of wearable or portable glucose monitoring devices. The growing adoption of these devices reflects a broader trend toward personalized and convenient healthcare solutions in the region. This surge in interest is driven by the desire for continuous and easy monitoring of glucose levels, contributing to improved management of diabetes and enhancing overall health outcomes in Saudi Arabia.

The U.A.E. dominates the market due to the rising diagnosis-seeking rate among its population. This trend is further fueled by the growing popularity of wearable and portable glucose monitoring devices. The increased adoption of these advanced technologies reflects a proactive approach toward healthcare management, contributing to the overall improvement in diagnostic practices and patient outcomes in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

중동 및 아프리카 진료소 진단 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 의료 중동 및 아프리카 진료소 진단 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 중동 및 아프리카 진료소 진단 시장에 미치는 영향. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 중동 및 아프리카 현장진단 시장 점유율 분석

중동 및 아프리카 진료소 진단 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 중동 및 아프리카 진료소 진단 시장과 관련된 회사의 초점에만 관련됩니다.

중동 및 아프리카 진료소 진단 시장에서 활동하는 주요 기업은 다음과 같습니다.

• BioTech Africa(남아프리카)
• 메드트로닉(아일랜드)
• BioRad Laboratories, Inc. (미국)
• PTS 진단(미국)
• 트리니티 바이오텍(아일랜드)
• Atlas Medical GmbH(영국)
• 애벗(미국)
• 시스멕스 주식회사(일본)
• 비오메리유(프랑스)
• QuidelOrtho Corporation(미국)
• BD(Becton, Dickinson and Company) (미국)
• 세키스이 다이어그노스틱스(미국)
• F. 호프만라 로슈 유한회사(스위스)
• Beckman Coulter, Inc. (미국)
• ACON 연구소, Inc. (미국)
• 노바 바이오메디컬(미국)
• 지멘스 헬스케어 GmbH(독일)

SKU-61547